U.K.'s NHS keeps buying into Varian; FDA clears silver-coated urinary catheter;

@FierceMedDev: ICYMI: Scientists make strides with real-time estrogen sensor. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Entellus wins FDA clearance for its endoscope to treat blocked sinus passages. Story | Follow @VarunSaxena2

@EmilyWFierce: JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. FiercePharma story | Follow @EmilyWFierce

> The U.K.'s National Health Service has ordered 20 TrueBeam machines from Varian Medical Systems ($VAR); this is on top of the 30 ordered in each of the last two years. The system is designed to deliver radiotherapy at more intense doses, which reduces the time to complete some cancer treatments. More

> Covalon ($COV) has nabbed an FDA clearance for its SilverCoat Silicone Foley Catheter, which is used to drain the bladder and is designed to reduce catheter-related urinary tract infections. More

> Olympus got FDA clearance for and launched its EZDilate Multi-Stage Endoscopic Balloon Dilator for GI visualization. More

Biotech News

@FierceBiotech: Star fund manager Woodford calls in ex-FBI agent to probe Northwest Bio allegations. Report | Follow @FierceBiotech

@JohnCFierce: Bristol-Myers gets elotuzumab OK for multiple myeloma -- Believe that makes 39 for the year so far. More | Follow @JohnCFierce

@DamianFierce: Actually, inversions are ... good? More from the NYT | Follow @DamianFierce

> Pfizer turns to GPCR experts at Heptares for a lineup of new drugs. Story

> Ex-Moderna chief scientist lands at PureTech to seed new biotechs. News

> Roche abandons a marquee antibiotics collaboration with Polyphor. Article

Pharma News

@FiercePharma: Report: Sanofi cooking up $12.7B animal health spinoff. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI: FDA warning letter says Dr Reddy's hid existence of QC testing lab where retesting was done. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Trump, Clinton lash out at Pfizer over Allergan deal. Article | Follow @CarlyHFierce

> Servier plots major layoffs in France after R&D setbacks, payer cuts. Story

> JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. More

> GSK's anticorruption overhaul in China may be hobbling sales. Article

Pharma Marketing News

> What caught our readers' fancy this year? Here's your top 10 FiercePharmaMarketing capsule. Editor's corner

> Amgen slaps $178K price on rare new leukemia drug Blincyto. More

> Top cancer doc takes to social media to fight rising prices. More

> Are Glaxo's China sales reforms putting it at a commercial disadvantage? More

> Big Pharma's bad rap made late-night TV, even before the Shkreli effect. More

Animal Health News

> Scientists roll out innovative health-tracking device for guide dogs. Report

> Report: Sanofi cooking up $12.7B animal health spinoff. Story

> Merck and Zoetis line up rival vaccines to fight new strain of dog flu. More

> Nexvet focuses first investor symposium on prospects for biotech in vet medicine. Article

> Petco abandons IPO plan in favor of $4.6B buyout. Item

Biotech IT News

> U.K. commits a further $375M to 100,000 Genomes Project. News

> Pfizer-Allergan merger raises questions about future of NuMedii deal. Item

> MediSapiens applies bioinformatics to find ideal leukemia treatment regimens. Report

> With PhIII trial coming up, Infinity strikes risk-based monitoring deal with Medidata. Story

> BGI slams brakes on Revolocity rollout, lays off staff in business rethink. Article